CD274 and Marinesco-Sjogren syndrome: In particular, PD-L1 negative patients or those patients with MSS and low TMB might potentially benefit from the combined immune checkpoint inhibitors and radiotherapy, given the possible increased PD-L1 expression, elevated TMB upon radiation therapy.